Development of dihydrochalcone-functionalized gold nanoparticles for augmented antineoplastic activity

• Published in: International journal of nanomedicine 2018-01, Vol.13, p.1917-1926
• Main Authors: Payne, Jason N, Badwaik, Vivek D, Waghwani, Hitesh K, Moolani, Harsh V, Tockstein, Sarah, Thompson, David H, Dakshinamurthy, Rajalingam
• Format: Article
• Language: English
• Subjects: Analysis; Antineoplastic Agents - administration & dosage; Antineoplastic Agents - chemistry; Antineoplastic Agents - pharmacology; Bioavailability; Cancer; Cancer therapies; Cancer treatment; Chalcones - chemistry; Chemistry; Displays (Marketing); Drug delivery systems; Drug Screening Assays, Antitumor - methods; Electron microscopy; Functional foods; Futures; Glucose; Gold; Gold - chemistry; Gold Nanoparticles; Handbooks; HeLa Cells; Humans; Hyperglycemia; Medical research; Metabolites; Metal Nanoparticles - administration & dosage; Metal Nanoparticles - chemistry; Microscopy; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molecular weight; Nanoparticles; Optical properties; Original Research; Particle Size; Pharmaceutical sciences; Phloretin; Phloretin - administration & dosage; Phlorhizin - administration & dosage; Phloridzin; Spectrometry, X-Ray Emission; Spectroscopy; Toxicity; Ultraviolet-visible spectroscopy; X-ray spectroscopy
• ISSN: 1178-2013; 1176-9114; 1178-2013
• DOI: 10.2147/IJN.S143506

Phloridzin, an antidiabetic and antineoplastic agent usually found in fruit trees, is a dihydrochalcone constituent that has a clinical/pharmaceutical significance as a sodium-glucose linked transport 2 (SGLT2) inhibitor. While the aglycone metabolite of phloridzin, phloretin, displays a reduced capacity of SGLT2 inhibition, this nutraceutical displays enhanced antineoplastic activity in comparison to phloridzin. The objective of this study was to develop gold nanoparticle (AuNP) mediated delivery of phloridzin and phloretin and explore their anticancer mechanism through conjugation of the dihydrochalcones and the AuNP cores. Phloridzin and phloretin conjugated AuNPs (Phl-AuNP and Pht-AuNP) were synthesized in single-step, rapid, biofriendly processes. The synthesized AuNPs morphology was characterized via transmission electron microscopy and ultraviolet-visible spectroscopy. The presence of phloridzin or phloretin was confirmed using scanning electron microscopy-energy dispersive x-ray spectroscopy. The percentage of organic component (phloridzin/phloretin) onto AuNPs surface was characterized using thermogravimetric analysis. Assessment of the antineoplastic potency of the dihydrochalcones conjugated AuNPs against cancerous cell lines (HeLa) was accomplished through monitoring via flow cytometry. The functionalized AuNPs were synthesized via a single-step method that relied only upon the redox potential of the conjugate itself and required no toxic chemicals. The synthesized Phl-AuNPs were found to be in the size range of 15±5 nm, whereas the Pht-AuNP were found to be 8±3 nm, placing both conjugated AuNPs well within the size range necessary for successful pharmaceutical applications. These assays demonstrate a significant increase in the cancerous cell toxicities as a result of the conjugation of the drugs to AuNPs, as indicated by the 17.45-fold increase in the efficacy of Pht-AuNPs over pure phloretin, and the 4.49-fold increase in efficacy of Phl-AuNP over pure phloridzin. We report a simple, biofriendly process using the reducing and capping potential of the dihydrochalcones, phloridzin and phloretin, to synthesize stable AuNPs that have promising futures as potential antineoplastic agents.